Related Experiment Video
Updated: Jun 4, 2026
07:00
A Method to Study the C924T Polymorphism of the Thromboxane A2 Receptor Gene
Published on: April 1, 2019
Optimization of warfarin dose by population-specific pharmacogenomic algorithm.
A Pavani1, S M Naushad, Y Rupasree
1Department of Clinical Pharmacology and Therapeutics, Nizam's Institute of Medical Sciences, Hyderabad, India.
The Pharmacogenomics Journal
|March 2, 2011
Summary
A new population-specific algorithm optimizes warfarin dosing by using genetic information and vitamin K intake. This pharmacogenomic approach improves accuracy and reduces adverse effects from incorrect warfarin doses.
Area of Science:
- Pharmacogenomics
- Clinical Pharmacology
Background:
- Warfarin dosing requires careful management to achieve therapeutic international normalized ratio (INR) and minimize bleeding risks.
- Existing warfarin dosing algorithms have limitations in accuracy across diverse populations.
Purpose of the Study:
- To develop and validate a population-specific pharmacogenomic algorithm for optimizing warfarin dosage.
- To improve the accuracy and clinical utility of warfarin dosing compared to existing methods.
Main Methods:
- A multiple linear regression model was employed using vitamin K intake and genetic polymorphisms in CYP2C9 (*2, *3) and VKORC1 (*3, *4, D36Y, -1639 G>A) as predictors.
- The newly developed algorithm was validated against established algorithms (Wadelius, IWC, Gage) and therapeutic warfarin dose.
Main Results:
- The new algorithm demonstrated superior accuracy (0.89 overall) compared to clinical data (0.51).
- It showed significantly improved sensitivity (0.87) and specificity (0.93) in predicting therapeutic warfarin response.
- The algorithm substantially reduced both overestimation (0.06) and underestimation (0.13) of the required warfarin dose.
Conclusions:
- The developed population-specific pharmacogenomic algorithm offers enhanced clinical utility for optimizing warfarin dosing.
- This approach can lead to decreased adverse events associated with suboptimal warfarin therapy.
Related Concept Videos
01:27Pharmacogenetics of Drug Metabolism: Overview
Genetic polymorphism in drug metabolism is crucial to the inter-individual variability observed in drug responses. Drug metabolism primarily involves the chemical modification of drugs and other xenobiotics to enhance their elimination by increasing their polarity. Two main classes of enzymes mediate this biotransformation process: Phase I enzymes, primarily cytochrome P450s, catalyze oxidation and reduction reactions, while other enzymes, such as esterases, mediate hydrolysis, and Phase II...
01:29Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
01:01Dosage Regimens: Partial Pharmacokinetic Parameters
It is not uncommon for complete drug pharmacokinetic profiles to remain elusive in pharmacokinetics. This necessitates certain educated assumptions by pharmacokineticists to determine appropriate dosage regimens without comprehensive pharmacokinetic data from animal or human studies. One prevalent assumption is setting the bioavailability factor, denoted as F, to 1 or 100%. This assumption caters to the scenario where a drug doesn't achieve full systemic absorption, resulting in the patient...
01:12Analysis of Population Pharmacokinetic Data
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
01:29Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
01:27Principles of Pharmacogenetics: Types of Genetic Variants
The human genome is over 99.9% identical between individuals, yet genetic differences exist at millions of bases. The human genome contains approximately 3 million variant positions per individual, many of which are heterozygous, contributing to genetic diversity and individual traits. Genetic variations include single-nucleotide polymorphisms (SNPs), insertions, deletions, and copy number variations (CNVs).SNPs, the most common variation, involve single-base changes in DNA. These can be...